Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.8K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Streptococcus uberis</i> Cas9-A Compact Type II-A Nuclease Recognizing a Unique PAM and Functional in Human Cells.

The CRISPR journal·2025
Same author

An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy.

Cell reports·2025
Same author

Structure-Guided Stapling of Dimeric Conformations and Linker Engineering Enhance Thermostability and Fine-Tune Activity of Bispecific VHH Cytokine Agonists.

Antibodies (Basel, Switzerland)·2025
Same author

IL-2 based cancer immunotherapies: an evolving paradigm.

Frontiers in immunology·2024
Same author

Responsive Neurostimulation of the Thalamus for the Treatment of Refractory Epilepsy.

Frontiers in human neuroscience·2022
Same author

An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma.

Science translational medicine·2021

Related Experiment Video

Updated: Mar 19, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.6K

PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia.

Ivan H Chan1, Dennis Van Hoof1, Marina Abramova1

  • 1ARMO BioSciences, Inc., 575 Chesapeake Drive, Redwood City, CA, 94063, United States of America.

Plos One
|June 15, 2016
PubMed
Summary

PEGylated Interleukin-10 (IL-10) harnesses immune cells, specifically Kupffer cells, to lower plasma cholesterol and liver fat. This novel mechanism shows potential for treating hypercholesterolemia and fatty liver disease.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.2K
Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

10.6K

Related Experiment Videos

Last Updated: Mar 19, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.6K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.2K
Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

10.6K

Area of Science:

  • Immunology
  • Metabolic Disease
  • Pharmacology

Background:

  • Interleukin-10 (IL-10) is a cytokine with diverse immune functions.
  • Previous research indicates IL-10 influences immune responses, but its role in cholesterol regulation is less understood.

Purpose of the Study:

  • To investigate the mechanism by which PEGylated rIL-10 (PEG-rIL-10) regulates plasma cholesterol in mice and humans.
  • To explore the potential of PEG-rIL-10 in treating hypercholesterolemia and liver conditions.

Main Methods:

  • Studies involved hypercholesterolemic mice and human cancer patients treated with PEG-rIL-10.
  • Phagocytotic cell depletion was used to assess their role in cholesterol regulation.
  • Measurements included plasma cholesterol, liver cholesterol, and liver triglycerides.

Main Results:

  • PEG-rIL-10 significantly lowers total plasma cholesterol by enhancing uptake in Kupffer cells (a type of phagocytotic cell).
  • Depletion of phagocytotic cells leads to increased plasma cholesterol levels.
  • Treatment with PEG-rIL-10 reduced liver cholesterol and triglycerides, reversing early liver fibrosis.

Conclusions:

  • Immunological cells, particularly Kupffer cells, play a crucial role in regulating total cholesterol levels.
  • PEG-rIL-10 offers a novel therapeutic approach by targeting these endogenous cholesterol-regulating immune populations.
  • PEG-rIL-10 demonstrates efficacy in lowering cholesterol and improving liver health, suggesting its potential for treating fatty liver disease and hypercholesterolemia.